Sarah James
Stock Analyst at Cantor Fitzgerald
(1.97)
# 3,132
Out of 5,050 analysts
299
Total ratings
35.11%
Success rate
-7.75%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $25 → $22 | $19.95 | +10.28% | 17 | Nov 7, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $36.91 | +11.08% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $78.50 | +21.03% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $227.92 | +9.69% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $203.28 | +20.52% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $146.69 | +22.71% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $21.42 | +68.07% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.85 | +40.35% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $475.38 | -6.60% | 21 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $316.86 | +38.86% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $261.99 | +39.32% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $21.36 | +31.09% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $250.91 | +15.58% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $312.74 | +55.08% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $19.53 | +48.49% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $5.04 | +197.91% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.07 | +369.48% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.34 | +36.33% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $122.90 | +8.22% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.83 | +92.40% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.60 | +8.70% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $8.87 | -43.63% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $16.41 | +27.97% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $77.30 | -49.55% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $71.32 | +170.61% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.78 | - | 2 | Mar 1, 2017 |
Acadia Healthcare Company
Nov 7, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $19.95
Upside: +10.28%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $36.91
Upside: +11.08%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $78.50
Upside: +21.03%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $227.92
Upside: +9.69%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $203.28
Upside: +20.52%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $146.69
Upside: +22.71%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $21.42
Upside: +68.07%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.85
Upside: +40.35%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $475.38
Upside: -6.60%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $316.86
Upside: +38.86%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $261.99
Upside: +39.32%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $21.36
Upside: +31.09%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $250.91
Upside: +15.58%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $312.74
Upside: +55.08%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $19.53
Upside: +48.49%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $5.04
Upside: +197.91%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.07
Upside: +369.48%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.34
Upside: +36.33%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $122.90
Upside: +8.22%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.83
Upside: +92.40%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.60
Upside: +8.70%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $8.87
Upside: -43.63%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $16.41
Upside: +27.97%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $77.30
Upside: -49.55%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $71.32
Upside: +170.61%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.78
Upside: -